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2193 – A0331
The risks of developing either dementia or visual impairment (VI) 
increase with age so potentially a large proportion of people with 
dementia will also be visually impaired. The main objective of the 
Prevalence of Visual Impairment in Dementia (or PrOVIDe) study was 
to measure the prevalence of a range of vision problems in people 
with dementia aged 60-89 years. Another objective was to determine 
estimates for the percentages of those with dementia likely to be 
able to perform successfully key elements of the eye examination.
Methods
PrOVIDe was a two-stage, mixed methods study, combining quantitative and qualitative research methods.
Stage 1
Was a quantitative, cross-sectional  prevalence 
study. Inclusion criteria were: individuals with a 
confirmed dementia (any type) diagnosis, aged 
60-89 years; individuals lacking the capacity to 
give informed consent to participate required a 
consultee who could give approval on their behalf.
• 708 participants with dementia  
aged 60-89 years
• 389 lived in their own homes –  
median age 80 years
• 319 in care homes – median age 83 years
Stage 2
In Stage 2 a combination of interviews with 
people living with dementia (recruited from Stage 
1) and focus groups (family carers, optometrists 
and professional care workers) were used to 
collect qualitative date.
• 36 interviews with people with dementia 
• Interviews / focus groups with family carers, 
professional care workers and eye care 
professionals 
• 119 participants in total across all groups
22% of participants reported not having had a sight test in the last two years: this included 19 
participants who had not been tested in the last 10 years .
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Almost 50% of VI was correctible with appropriate spectacle prescriptions. Once VI correctible with 
spectacles was removed, almost 50% of the remaining VI was due to  cataracts, and thus potentially 
correctible with surgery. 
The prevalence of VI in the PrOVIDe sample was similar to the best comparator data for the general 
population in the UK, but the  study findings suggest that eye care for people with dementia could 
be improved, especially in terms of understanding the  potential barriers to accessing cataract surgery, 
mechanisms for improving use of spectacles / refractive correction, and the factors driving the 
significantly higher rates of VI found among the PrOVIDe participants living in residential care homes.
A single cause of post refraction visual impairment  
has been identified for each participant
Stage 1 Participants
VA worse than 6/12
Type of Visual 
Impairment
Full sample  
N = 708 
% (n) 
[95%CI]
Group 1 
N = 389 
% (n) 
[95%CI]
Group 2 
N = 319 
% (n) 
[95%CI]
Difference in 
proportions 
between  
Groups 1 & 2%† 
[95% CI]
Presenting 32.5 (191) 
[28.7, 36.5]
21.8 (82) 
[17.8, 26.4] 
51.4 (109) 
[44.5, 58.3] 
-29.6  
[-37.9, -21.3] 
p<0.001
Missing data % (n) 16.9 (120) 3.3 (13) 33.5 (107)
Uncorrected or  
under-corrected
14.3 (84)
[11.7, 17.5] 
10.6 (40)
[7.8, 14.3] 
21.0 (44)
[15.8, 27.2] 
-10.4
[-17.0, -3.6]
p<0.01
Missing data % (n)
17.2 (122) 3.3 (13) 34.2 (109)
Post-refraction
18.2 (107) 
[15.2, 21.5] 
11.4 (43)
[8.4, 15.1] 
30.2 (64)
[24.2, 36.9] 
-18.8
[-26.1, -11.5] 
p<0.001
Missing data % (n) 16.7 (118) 2.8 (11) 33.5 (107)
VA worse than 6/18
Type of Visual 
Impairment
Full sample 
N = 708
% (n)
[95%CI
Group 1
N = 389
% (n)
[95%CI
Group 2
N = 319
% (n)
[95%CI
Difference in 
proportions 
between  
Groups 1 & 2†
[95% CI]
Presenting
16.3 (96)
[13.5, 19.6] 
10.6 (40)
[7.8, 14.3] 
26.4 (56)
[20.7, 33.0] 
-15.8
[-22.8, -8.7] p<0.001
Missing data % (n) 16.9 (120) 3.3 (13) 33.5 (107)
Uncorrected or  
under-corrected
7.7 (45)
[5.7, 10.2] 
5.1 (19)
[3.2, 7.9] 
12.4 (26)
[8.4, 17.8] 
-7.3
[-12.7, -2.0]
p<0.01
Missing data % (n) 17.2 (122) 3.3 (13) 34.2 (109)
Post-refraction
8.6 (51)
[6.6, 11.3] 
5.6 (21)
[3.6, 8.5] 
14.2 (30)
[9.9, 19.7] 
-8.6
[-14.2, -3.0] p<0.001
Missing data % (n) 16.7 (118) 2.8 (11) 33.5 (107)
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